Impact of the NK Cell Receptor LIR-1 (ILT-2/CD85j/LILRB1) on Cytotoxicity against Multiple Myeloma by Silke Heidenreich, Christine zu Eulenburg, York Hildebrandt, Thomas Stübig, Heidi Sierich, Anita Badbaran, Thomas H. Eiermann, Thomas M. C. Binder, Nicolaus Kröger

Get full text

App-based support for breast cancer patients to reduce psychological distress during therapy and survivorship – a multicentric randomized controlled trial by Josefine Wolff, Josefine Wolff, Svenja Seidel, Pia Wuelfing, Michael Patrick Lux, Christine zu Eulenburg, Martin Smollich, Freerk Baumann, Stephan Seitz, Sherko Kuemmel, Marc Thill, Joke Tio, Michael Braun, Hannah Hollaender, Angenla Seitz, Felicitas Horn, Nadia Harbeck, Rachel Wuerstlein

Get full text

De BPSD-DS evaluatieschaal voor dementiegerelateerde gedragsveranderingen bij mensen met downsyndroom by Alain D. Dekker, Yannick Vermeiren, Gonny Beugelsdijk, Mieke Schippers, Lyanne Hassefras, José Eleveld, Sharina Grefelman, Roelie Fopma, Monique Bomer-Veenboer, G. Danielle E. Oosterling, Esther Scholten, Marleen Tollenaere, Gert Van Goethem, Christine zu Eulenburg, Antonia M. W. Coppus, Peter P. De Deyn

Get full text

HER2-low status as a distinct breast cancer subtype: myth or truth? Analysis of the WSG trials WSG-ADAPT-HR+/HER2-, WSG-PlanB, and WSG-ADAPT-TN by Gilda Schmidt, Oleg Gluz, Matthias Christgen, Mattea Reinisch, Sherko Kümmel, Ulrike Nitz, Michael Braun, Bahriye Aktas, Kerstin Lüdtke-Heckenkamp, Helmut Forstbauer, Eva-Maria Grischke, Claudia Schumacher, Rolf Mahlberg, Wolfram Malter, Toralf Reimer, Benno Nuding, Andrea Stefek, Rachel Wuerstlein, Monika Graeser, Katarzyna Jóźwiak, Sandy Burmeister, Christine zu Eulenburg, Michael Lauseker, Cornelia Kolberg-Liedtke, Aleix Prat, Peter Schmid, Rick Baehner, Hans Heinrich Kreipe, Erich-Franz Solomayer, Nadia Harbeck, on behalf of the West German Stud y Group investigators

Get full text